The updated guidance prioritizes older adults, high-risk individuals, and those who have never been vaccinated.
On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...
Up-to-date vaccination remains the most effective way to prevent severe COVID-19 illness, new research from the World Health ...
Health experts are reinforcing the point that full vaccination remains highly effective against severe illness and death caused by COVID-19 as federal regulators consider the possibility of ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...
COVID booster vaccinations reduced the likelihood of hospitalization related to COVID in patients with autoimmune diseases, with monovalent and bivalent booster vaccines showing 38% and 32% ...
Covid vaccines continue to protect against serious illness and death, especially for people ages 65 and older, although the benefits for younger adults are not as clear, according to a large new study ...
The Food and Drug Administration on Tuesday outlined new regulatory guidance for future Covid-19 vaccine boosters, setting stricter approval standards for healthy Americans. The agency said it wants ...
LOS ANGELES -- U.S. regulators issued new guidance this week shortening the time that people who received Moderna or Pfizer's COVID-19 vaccine have to wait for a booster, and it's different than the ...
Some people vaccinated against COVID-19 initially acquire strong levels of neutralizing antibodies but then experience rapid declines. Measuring immunoglobulin A antibody titers post-vaccination could ...
The US Centers for Disease Control and Prevention strengthened recommendations for booster doses of coronavirus vaccine Monday, saying all adults should get boosted six months after the second dose of ...